Induction of myelodysplasia by myeloid-derived suppressor cells. - Wikidata - wikimedia - TriplyDB

Induction of myelodysplasia by myeloid-derived suppressor cells.

Induction of myelodysplasia by myeloid-derived suppressor cells.

http://www.wikidata.org/entity/Q37259216

about

Bone Marrow Immunity and Myelodysplasia Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes Improving cancer immunotherapy by targeting the STATe of MDSCs Stress and Non-Stress Roles of Inflammatory Signals during HSC Emergence and Maintenance The Role of Toll-Like Receptors in Hematopoietic Malignancies Phenotype, development, and biological function of myeloid-derived suppressor cells Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia.Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes.A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response prediction.Inactivation of DAP12 in PMN inhibits TREM1-mediated activation in rheumatoid arthritis Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells Myeloid derived suppressor cells in chronic myeloid leukemia.Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling CD14 Is a Co-Receptor for TLR4 in the S100A9-Induced Pro-Inflammatory Response in Monocytes Context Matters: Distinct Disease Outcomes as a Result of Crebbp Hemizygosity in Different Mouse Bone Marrow Compartments COX-2 promotes metastasis in nasopharyngeal carcinoma by mediating interactions between cancer cells and myeloid-derived suppressor cells.Biology of the bone marrow microenvironment and myelodysplastic syndromes.Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors.Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9 Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti-PD-1 Therapy The Systemic Profile of Soluble Immune Mediators in Patients with Myelodysplastic Syndromes.Immunological derangement in hypocellular myelodysplastic syndromes.Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets.The inflammatory microenvironment in MDS.Toll-like receptor signaling in hematopoietic homeostasis and the pathogenesis of hematologic diseases.The microenvironment in myelodysplastic syndromes: niche-mediated disease initiation and progression.New Insights into the Pathogenesis of MDS and the rational therapeutic opportunities.Immune checkpoint pathways: perspectives on myeloid malignancies.Stem and progenitor cell alterations in myelodysplastic syndromes.Emerging biological therapies for the treatment of myelodysplastic syndromes.Myeloid-derived suppressor cells as effectors of immune suppression in cancer.Programmed cell death-1 pathway inhibition in myeloid malignancies: implications for myeloproliferative neoplasms.Mesenchymal stromal cells in myeloid malignancies.Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome.

P2860

Q26739239-86345E67-042E-4955-AFB1-985CF3D3ECDC Q26744481-296AF065-87A5-460F-A420-82805CCFF7CF Q26746104-3ED92E47-AF1D-4423-B795-B82D3AF3CC7B Q26859843-1738A4A8-4968-48DE-84EA-EFF7B728FA17 Q27015288-7A69AB3A-E452-4800-BC2F-33AF47321B20 Q28066797-A774C12B-1EED-4DFE-BFB5-A580ACED25A4 Q28072920-0EA6C40E-06CB-4060-9781-2BA77229FCC1 Q28077740-E4E704AB-6E57-4A79-825D-D59BEC25326A Q28079046-BFEEA0E6-47B2-4AB1-B72E-F712D6D5FCF1 Q28256749-6AB992EE-9470-4309-9787-D5F1317FBACC Q33585293-233A35B1-EC6E-42C4-8CC1-8CE1010C1EC6 Q33652652-99673FAF-1CC7-4EC1-820B-B76D17966E40 Q33739020-37676109-6236-4A63-9F1F-019E0DCC7BAF Q33828560-9EF33933-1F16-4CC8-B362-D14CDCEA99D3 Q35038322-2880B623-915F-4C93-A289-17A7F21D9E63 Q35071167-35B7841D-3460-4251-A246-727CBA52F23D Q35607293-97366E11-3B44-4D06-894B-43C9A3937691 Q35609094-87396787-A65E-4B0B-B0A4-C0948B2152B4 Q35803662-AC8000C6-5D3D-43EF-913B-253637D91AF9 Q36030737-D3A993DA-E275-4B17-9C80-0E44EB73345C Q36079807-8006C9D9-4333-4CFC-851C-9C98FE275F73 Q36110362-7E22BC91-F631-4564-983D-584B7FD88DDC Q36201068-3506D997-5CCA-4E06-8F00-1B4F14D81D5C Q36557537-77A63FF6-AD97-4D61-8391-3F58BB3F5A27 Q36909178-785FDF8A-22BC-4CE4-BE00-47AA75146CD1 Q36963592-529E6AE1-D9CC-4F76-8391-EDB94366C258 Q37134517-61AB6219-C910-46AD-A5DA-5E67470C381C Q37724605-9CC53B90-0D50-4D66-A4FA-C0A4730B1F54 Q38269370-7B9D80DB-39AA-4298-8F67-E4068798DABE Q38348119-951B70A5-BB03-4B78-AB0A-67AABD20AFF2 Q38571471-0D3F72CD-8786-4DA0-BA7F-76E17A9F265E Q38615755-AEE4B6AA-CC1E-4C08-B3F5-0438486E6E0E Q38687894-03354BC2-7070-4432-84F4-129D519809ED Q38750608-ECC8E37C-D8B6-432A-B677-46F5DB4BE81A Q38761791-38FD1568-EC88-4F5D-9C24-CED5D2D0CBD1 Q38834981-1B0AEF5B-B739-43D5-AA7C-35CF727817CF Q38864758-098D6DF0-A8F5-43E3-ACE2-EFBABDB3D09C Q39072004-DC8FD89F-9827-4FD0-A1D0-FF7CA0184282 Q39090002-D293C38D-B5EA-40A4-8D54-0AC0326BB90E Q39279547-47C695E0-68F1-4599-9525-3EB2B4926282

P2860

Induction of myelodysplasia by myeloid-derived suppressor cells.

http://www.wikidata.org/entity/Q37259216

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Induction of myelodysplasia by myeloid-derived suppressor cells.

@en

Induction of myelodysplasia by myeloid-derived suppressor cells.

@nl

type

label

Induction of myelodysplasia by myeloid-derived suppressor cells.

@en

Induction of myelodysplasia by myeloid-derived suppressor cells.

@nl

prefLabel

Induction of myelodysplasia by myeloid-derived suppressor cells.

@en

Induction of myelodysplasia by myeloid-derived suppressor cells.

@nl

P1433

Q37259216-39611467-D304-4F3E-8149-8670B7102531

P1476

Q37259216-E24FBC62-7F03-41B8-B952-C4164D8D4028

P2093

Q37259216-2590E9C3-AE48-4651-86D4-9C458F421429

Q37259216-2A4242D9-6994-434C-8E77-9E17B57F8613

Q37259216-57B9B1DB-3A68-4BD3-BCE6-2AB685AFFB4E

Q37259216-6CFD8A5B-6AE8-435C-810E-8BDEEFE43050

Q37259216-7732FBF0-28A0-4B1D-B519-BE866BCA0E13

Q37259216-794551BD-DDDA-4686-B354-6C56500D498F

Q37259216-7A7E3DE5-CE8D-4B4E-B88F-FCF968F74950

Q37259216-831004CE-0D99-4DB1-949A-39EAC11559CE

Q37259216-917424B0-84DC-476C-8FB7-D505C5811FCD

Q37259216-9F68AEC0-B4C0-47BB-B871-7A5CC9E8AF06

P2860

Q37259216-0267E89B-8D31-4B8D-A926-D462F6CF126C

Q37259216-039229DE-665E-46EA-8D71-2B19B6EF20FA

Q37259216-1194672D-6301-43F7-9055-548ACB07D9DE

Q37259216-11D31CB6-5EAD-42C4-B105-4CA4835FB9D3

Q37259216-1C517109-C182-4F0D-8C1B-6B1E4BD99598

Q37259216-1CAA8091-BC3F-4C76-8027-5FED3688635B

Q37259216-214B0728-087A-4B53-929D-16CE89A1F964

Q37259216-2243A0F5-E802-405B-B6F4-B48A4E7F84B6

Q37259216-2BE9E3D9-B0CF-4DDF-ADBC-EEF3E24A9A1C

Q37259216-30889A68-53C1-4E75-BCFD-82C1ABC1F97B

P304

Q37259216-052B8471-2D06-4D5E-A113-62F60BCAD827

P31

Q37259216-5B465D3E-5DDD-434A-A996-17671D453E11

P356

Q37259216-FB26DEA7-EEFC-43B6-93B7-5D7744137C7A

P407

Q37259216-77F7AD4A-3BE2-4DE8-A0AB-BC9896E88F91

P433

Q37259216-F7C13F75-F53D-4760-A468-26E3A65B7A56

P478

Q37259216-618ED380-3818-495E-86E8-AB762EB8BF4E

P50

Q37259216-585340C5-B216-4836-B82D-15708F44D152

Q37259216-6BBA5FA4-29FD-4B49-889B-2A51F013E9D3

P577

Q37259216-56CF6CD0-413D-40BA-984B-386B2C5A1C5B

P5875

Q37259216-266BD8FC-7945-4B62-9F0F-ABE54B753AFE

P698

Q37259216-70CBBE37-DDE7-4BAE-865B-93694058F1C9

P932

Q37259216-99DC08F6-766F-405C-9714-D2FDAA53ED5D

P356

P1433

Journal of Clinical Investigation

P1476

Induction of myelodysplasia by myeloid-derived suppressor cells

@en

P2093

Dahui Qin

http://www.w3.org/2001/XMLSchema#string

Dmitry I Gabrilovich

http://www.w3.org/2001/XMLSchema#string

Harry Dolstra

http://www.w3.org/2001/XMLSchema#string

Huaquan Wang

http://www.w3.org/2001/XMLSchema#string

Je-in Youn

http://www.w3.org/2001/XMLSchema#string

Jianguo Tao

http://www.w3.org/2001/XMLSchema#string

John Cannon

http://www.w3.org/2001/XMLSchema#string

Julie Djeu

http://www.w3.org/2001/XMLSchema#string

Junmin Zhou

http://www.w3.org/2001/XMLSchema#string

Ling Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells

Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro

Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation

Myeloid-derived suppressor cells: linking inflammation and cancer

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML

Demand-adapted regulation of early hematopoiesis in infection and inflammation

A Bony Fish Immunological Receptor of the NITR Multigene Family Mediates Allogeneic Recognition

Myeloid-derived suppressor cells as regulators of the immune system

Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis

P304

4595-4611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI67580

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Erika A. Eksioglu

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258444236

http://www.w3.org/2001/XMLSchema#string

P698

24216507

http://www.w3.org/2001/XMLSchema#string

P932

3809779

http://www.w3.org/2001/XMLSchema#string